Clinical Trials Logo

Lung Cancer clinical trials

View clinical trials related to Lung Cancer.

Filter by:

NCT ID: NCT02719717 Completed - Lung Cancer Clinical Trials

Ultrasonic Energy for Pulmonary Artery Branch Sealing During VATS Lobectomy

VATS PA-ACE
Start date: June 2016
Phase: N/A
Study type: Interventional

This research program consists of a prospective, multi-institutional Phase 2 trial and an economic cost-effectiveness analysis for the use of ACE+7 in VATS lobectomy/segmentectomy compared to traditional techniques. It will be left up to the study credentialed surgeon investigator to decide the suitability of PA branches for sealing. This will be decided intra-operatively based on anatomy, vascular dissection and length as well as patient specific factors.

NCT ID: NCT02716051 Completed - Lung Cancer Clinical Trials

Wholebody MRI In Lung Cancer StagiNg

WISLON
Start date: March 2016
Phase: N/A
Study type: Interventional

Magnetic Resonnace Imaging (MRI) and Positron Emission Tomography (PET) can be both used in detection of nodes in patients with cell lung cancer (NSCLC). However, the cardiorespiratory synchronization in the MRI, allowing acquisition of synchronous images with breathing and heart movements should increase the sensitivity of detection of pathologic mediastinal lymph nodes. Given its high sensitivity, whole-body MRI with diffusion could possibly be at least as informative as PET, while being less expensive, not radiant. The purpose of this study is to evaluate the performance of whole-body MRI with diffusion with cardiorespiratory synchronization, on the detection of mediastinal nodes (which are known to be less well detected by MRI) compared to PET.

NCT ID: NCT02713867 Completed - Lung Cancer Clinical Trials

A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks

CheckMate 384
Start date: May 24, 2016
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to compare PFS (progression-free survival) rate at 6 months and at 1 year after randomization, of Nivolumab 480 mg every 4 weeks with nivolumab 240 mg every 2 weeks in subjects with advanced/metastatic (Stage IIIb/IV) NSCLC (non-Sq and Sq).

NCT ID: NCT02710565 Completed - Lung Cancer Clinical Trials

Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma

EBUS
Start date: February 2016
Phase: N/A
Study type: Interventional

Participants who are scheduled to have an endo bronchial ultrasound (EBUS) trans bronchial needle aspiration (TBNA) will provide additional samples. These samples will then be sent to Imperial College London to see whether a cell line can be grown. If growth is successful then the samples will be returned to our pathology department to see if grading is possible and then to compare these results with the previous diagnostic samples. The cell line samples will not be used for patient diagnosis.

NCT ID: NCT02709720 Completed - Lung Cancer Clinical Trials

Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLC

NORA
Start date: April 15, 2016
Phase: Phase 2
Study type: Interventional

Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy and subsequent concomitantly with radiotherapy (RT) in patients with lung cancer (NSCLC) locally advanced unresectable

NCT ID: NCT02705365 Completed - Lung Cancer Clinical Trials

Patient Navigation for Lung Screening at MGH Community Health Centers

Start date: February 1, 2016
Phase: N/A
Study type: Interventional

To develop and implement a patient navigator (PN) program for lung screening and smoking cessation in community health center primary care practices. This program will be evaluated in a randomized controlled trial of primary care patients who currently smoke.

NCT ID: NCT02687997 Completed - Lung Cancer Clinical Trials

Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort

SAILS
Start date: February 2016
Phase: N/A
Study type: Interventional

Prospective study of sleep disordered breathing in a lung cancer screening cohort.

NCT ID: NCT02679872 Completed - Lung Cancer Clinical Trials

Video-assisted Thoracoscopic Surgery Teams' Perception of Non-technical Skills

Start date: February 2016
Phase: N/A
Study type: Observational

Good non-technical skills (NTS) have been shown to prevent adverse events and errors. Improvements of NTS can be achieved by simulation based-team training.The NTS of the operating theatre team performing video-assisted thoracoscopic surgery (VATS) is speculated to differ fra open thoracic surgery, as is the case with technical skills; however, these have not been investigated. The aim of this study is to explore which NTS the members of the VATS team perceive to be most important to patient care and safety. Exploration will be done through a deductive, qualitative analysis of semi-structured group and individual interviews with VATS team members. A theoretical perspective of Hollnagels Safety-II will be taken using the taxonomy of Oxford Non-Technical Skills (NOTECHS) system with the aim of informing patient safety.

NCT ID: NCT02665078 Completed - Lung Cancer Clinical Trials

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

Start date: January 2015
Phase: N/A
Study type: Observational

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross section with maximum diameter. The ultrasound image with size measurement of the tumor will be recorded using an ultrasound scanner (EU-Y0008, OLYMPUS MEDICALSYSTEMS CORP., Tokyo, Japan). Next, the bronchial stump of the specimen will be opened and a small sized endotracheal tube will be inserted to inflate and deflate the lung. After inflation of the lung, the tumor will be evaluated by XLTF-UC180 to see the difference in ultrasound images between deflated and inflated lung. After ultrasound evaluation, the specimen will be delivered directly to the pathology laboratory and the actual tumor size and histological diagnosis will be determined. In addition, we will evaluate the differences between US image and pathological morphology using HE slides of lung tumor. We will work together with the surgical team to confirm sign off of specimens.

NCT ID: NCT02664259 Completed - Lung Cancer Clinical Trials

UTB-VBN-EBUS With or Without Fluoroscopy for the Diagnosis of PPLs

Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the feasibility,efficacy and safety of ultrathin bronchoscopy(UTB) combined with virtual bronchoscopic navigation(VBN) and endobronchial ultrasound(EBUS) for the diagnosis of peripheral pulmonary lesions (PPLs) without radiographic fluoroscopy.